1-20 of 1268 Search Results for

survivor

Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Book Chapter
Series: Frontiers of Hormone Research
Volume: 54
Published: 17 December 2021
10.1159/000514692
EISBN: 978-3-318-06791-0
... Abstract Cancer therapy-induced bone loss (CTIBL), occurring especially in hormone-treated breast and prostate cancer patients, is a noteworthy long-term consequence of cancer treatments. Because of its negative impact on the quality life of cancer survivors, it deserves much attention. We here...
Book Chapter
Series: Endocrine Development
Volume: 15
Published: 26 February 2009
10.1159/000207613
EISBN: 978-3-8055-9038-9
... Abstract Advances in childhood cancer treatment over the past decades have significantly improved survival, resulting in a rapidly enlarging group of childhood cancer survivors. There is much concern, however, about the effects of treatment on reproductive potential. In women there is evidence...
Book
Book Cover Image
Series: Frontiers of Hormone Research
Volume: 54
Published: 17 December 2021
10.1159/isbn.978-3-318-06791-0
EISBN: 978-3-318-06791-0
Book Chapter
Book Chapter
Series: Medicine and Sport Science
Volume: 52
Published: 05 June 2008
10.1159/000134301
EISBN: 978-3-8055-8490-6
... Abstract Background/Aims: Treatment for breast cancer produces side effects that diminishfunctional capacity and quality of life (QOL) among survivors. Tai Chi Chuan (TCC) is amoderate form of exercise that may improve functional capacity and QOL in these individuals.Women who completed...
Book Chapter
Book Chapter
Series: Frontiers of Hormone Research
Volume: 54
Published: 17 December 2021
10.1159/000519414
EISBN: 978-3-318-06791-0
... attention as a crucial determinant of long-term cardiovascular risk in cancer survivors. Several risk factors have been associated with metabolic syndrome after cancer treatments, even if the pathophysiological mechanisms of this association are not fully understood. This chapter reviews the clinical...
Book Chapter
Series: Endocrine Development
Volume: 15
Published: 26 February 2009
10.1159/000207614
EISBN: 978-3-8055-9038-9
... Abstract Today more than 75% of children treated for cancer will be cured, and attention is focusing on the late effects of treatments for these long-term survivors. Treatment-related morbidity is diverse, with potential effects on the endocrine system (growth, puberty, fertility, pituitary...
Book Chapter
Series: Progress in Tumor Research
Volume: 43
Published: 08 September 2016
10.1159/000447040
EISBN: 978-3-318-05912-0
... decades, the number of adolescents and young adult (AYA) cancer survivors are increasing. The survival rate has radically changed from 1 in 3 to 3 in 4 childhood AYA survivors. Concurrently, there has been a growing medical interest in these survivors, their health and their emotional growing up...
Book Chapter
Book Chapter
Series: Frontiers of Hormone Research
Volume: 54
Published: 17 December 2021
10.1159/000515111
EISBN: 978-3-318-06791-0
... Abstract Growth hormone deficiency (GHD) is common in childhood cancer survivors (CCS). Major risk factors for GHD include radiation therapy, both cranial and total body irradiation, and tumor location. Some newer anti-cancer therapies may impact growth and the GH-IGF-1 axis as well. While...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 54
Published: 17 December 2021
10.1159/000515460
EISBN: 978-3-318-06791-0
... Abstract Modern advances in oncological treatments determined a significant improvement in survival rates for several malignancies. Nevertheless, survivorship and quality of life of cancer survivors may be negatively impaired by metabolic and endocrine side effects related to anticancer...
Book Chapter
Book Chapter
Series: Frontiers of Hormone Research
Volume: 54
Published: 17 December 2021
10.1159/000513806
EISBN: 978-3-318-06791-0
... Abstract Hypothalamic-pituitary (HP) dysfunctions are commonly reported complications in survivors of childhood cancer. These include growth hormone deficiency, luteinizing hormone/follicle-stimulating hormone deficiency, thyroid-stimulating hormone deficiency, adrenocorticotropic hormone...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 54
Published: 17 December 2021
10.1159/000513805
EISBN: 978-3-318-06791-0
... Abstract Childhood cancer survivors (CCS) are at increased risk of developing thyroid disorders during follow-up. Radiation therapy to a field that includes the thyroid gland and 131 I-meta-iodobenzylguanidine ( 131 I-MIBG) treatment are the main risk factors for thyroid sequelae, which...
Book Chapter
Series: Progress in Neurological Surgery
Volume: 23
Published: 13 March 2009
10.1159/000210059
EISBN: 978-3-8055-9078-5
... Abstract Purpose: To assess the quality of life (QOL) of extremely long-time survivors with germinoma mainly treated with radiotherapy. Patients and Methods: We enrolled 52 of 68 patients who received radiotherapy between 1968 and 1995 at our hospital. They were 41 males and 11 females...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 54
Published: 17 December 2021
10.1159/000513921
EISBN: 978-3-318-06791-0
... Abstract Long-term cancer survivors are at high risk of developing cardiac complications from the treatments, both systemic agents and thoracic irradiation, received to cure the primary tumor. Modern advances, particularly in the field of radiotherapy, aim to reduce the risk of cardiovascular...
Book Chapter
Book Chapter
Series: Frontiers of Hormone Research
Volume: 54
Published: 17 December 2021
EISBN: 978-3-318-06791-0
... with cancer in 2000–07: Population-based data from EUROCARE-5. Lancet Oncol 2016;17:896–906. 3. Mullan F: Seasons of survival: reflections of a physician with cancer. N Engl J Med 1985;313:270–273. 4. Armstrong GT, Chen Y, Yasui Y, et al: Reduction in late mortality among 5-year survivors of childhood...
Book Chapter
Series: Frontiers of Hormone Research
Volume: 54
Published: 17 December 2021
10.1159/000518816
EISBN: 978-3-318-06791-0
... Abstract Long-term childhood adolescent and young adult (CAYA) cancer survivors may develop health conditions that often coexist at young adulthood or middle age and that normally occur in persons aged 65 years and older, including cardiovascular and musculoskeletal diseases, metabolic syndrome...